Paul S. Martin

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A phase II trial evaluating the efficacy of high‐dose Radioiodinated Tositumomab (Anti‐CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high‐risk relapsed or refractory non‐hodgkin lymphoma”.

A phase II trial evaluating the efficacy of high‐dose Radioiodinated Tositumomab (Anti‐CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high‐risk relapsed or refractory non‐hodgkin lymphoma

American Journal of Hematology(2020)10.1002/ajh.25818

N/A

0.360DataRank · unranked

10 citations

Joseph G. Rajendran, Darrell R. Fisher, Frederick R. Appelbaum, Ryan D. Cassaday, Paul S. Martin +8 more

Anakinra‐Associated Systemic Amyloidosis

Arthritis & Rheumatology(2023)10.1002/art.42664

N/A

0DataRank · unranked

14 citations

Surendra Dasari, Anvitha Metpally, Kat Uss, Leslie Castelo‐Soccio, Theo Heller +16 more